ZYME vs ARVN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
ZYME
ARVN
Investment Advisor Scores
ARVN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ZYME | ARVN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 20.8333 | 17.8571 | ARVN |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -90.6% | 1014.7% | ARVN |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.2/100 | 60.2/100 | ARVN |
| Profit Margin | 0.0% | 2.9% | ARVN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | BUY | ARVN |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ZYME
MarkupPrice above SMA50, rising 50-day trend (4.4% over 20 days), RSI 61
ARVN
NeutralMixed signals - no dominant trend phase, RSI 51
Fundamentals Snapshot
| Metric | ZYME | ARVN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 31.5 | -2.4 |
| Trailing P/E | — | 29.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.9% | 10.1% |
| Gross Margin | -2.5% | 1.0% |
| Operating Margin | -9.2% | 0.7% |
| EPS | -2.02 | 0.26 |
| Dividend Yield | — | — |